NEO·64049M209·US·equity·Healthcare - Diagnostics & Research-13D/G
NEO (NEOGENOMICS INC) is held by 127 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($148.1M), FIRST TRUST ADVISORS LP ($45.7M), STATE STREET CORP ($38M). Net institutional sentiment: Mixed.
See how NEO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer